NDC 68382-256-30 - oxybutynin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68382-256
- Requested NDC
- 68382-256-30
- Package NDCs from labels
- 68382-256-14, 68382-256-01, 68382-256-16, 68382-256-05, 68382-256-30, 68382-256-77, 68382-256-06
- Manufacturer
- NCS HealthCare of KY, LLC dba Vangard Labs
- Effective date
- 2024-09-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| oxybutynin - NCS HealthCare of KY, LLC dba Vangard Labs | NCS HealthCare of KY, LLC dba Vangard Labs | 2024-09-13 | HUMAN PRESCRIPTION DRUG LABEL |
| oxybutynin - Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | 2023-11-07 | HUMAN PRESCRIPTION DRUG LABEL |
| oxybutynin - A-S Medication Solutions | A-S Medication Solutions | 2023-02-06 | HUMAN PRESCRIPTION DRUG LABEL |
| oxybutynin - Bryant Ranch Prepack | Bryant Ranch Prepack | 2021-12-28 | HUMAN PRESCRIPTION DRUG LABEL |
| oxybutynin - REMEDYREPACK INC. | REMEDYREPACK INC. | 2019-09-30 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68382-256-01 | oxybutynin | 100 in 1 BOTTLE | TABLET, FILM COATED, EXTENDED RE | 100 | 7 | |
| 68382-256-05 | oxybutynin | 500 in 1 BOTTLE | TABLET, FILM COATED, EXTENDED RE | 500 | 7 | |
| 68382-256-06 | oxybutynin | 30 in 1 BOTTLE | TABLET, FILM COATED, EXTENDED RE | 30 | 7 | |
| 68382-256-14 | oxybutynin | 60 in 1 BOTTLE | TABLET, FILM COATED, EXTENDED RE | 60 | 7 | |
| 68382-256-16 | oxybutynin | 90 in 1 BOTTLE | TABLET, FILM COATED, EXTENDED RE | 90 | 7 | |
| 68382-256-30 | oxybutynin | 10 in 1 BLISTER PACK | TABLET, FILM COATED, EXTENDED RE | 10 | 7 | |
| 68382-256-77 | oxybutynin | 10 in 1 CARTON | TABLET, FILM COATED, EXTENDED RE | 10 | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68382-256-01 | EA - Each | 68382-256 | 776d3361-0a48-4302-8f10-9fb57065cfff | 1 | 2018-03-08 |
| 68382-256-05 | EA - Each | 68382-256 | 25a49211-2204-4e59-97d7-95709b03d7d6 | 1 | 2018-03-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | PD-Rx Pharmaceuticals, Inc. | 3a319017-4e25-402e-8ba0-63b9f1eb707e | 2026-11-04 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride Extended Release | OXYBUTYNIN CHLORIDE | PD-Rx Pharmaceuticals, Inc. | e466d963-469a-4b1c-87f9-2e3e1e9bdf3d | 2026-11-02 | Warnings, Adverse reactions | 863619 L9F3D9RENQ |
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | PD-Rx Pharmaceuticals, Inc. | 8bd5dce0-d56a-4e64-8de7-e7cd7775526b | 2026-11-02 | Warnings, Adverse reactions | L9F3D9RENQ |
| Clear Eyes Triple Relief | POLYVINYL ALCOHOL AND POVIDONE AND TETRAHYDROZOLINE HYDROCHLORIDE | Prestige Brands Holdings, Inc. | 1269a1a6-843d-4d08-bb3c-c1f3d2e7080d | 2026-10-23 | Warnings | FZ989GH94E |
| Artificial Tears | GLYCERIN | Preferred Pharmaceuticals Inc. | dd646c72-8f47-43c6-a734-db0dcc8cd4d1 | 2026-10-14 | Warnings | 3NXW29V3WO |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Cardinal Health 107, LLC | 8455b543-81ce-4522-ae9b-8396f944945c | 2026-10-12 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Preferred Pharmaceuticals Inc. | 0e002fe8-fa3f-4a7d-84df-0c6e031e6ae4 | 2026-10-09 | Warnings, Adverse reactions | L9F3D9RENQ |
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | A-S Medication Solutions | a1674ddc-44f5-4638-8415-ef02ab6af7cc | 2026-09-18 | Warnings, Adverse reactions | L9F3D9RENQ |
| REFRESH Classic | POLYVINYL ALCOHOL, POVIDONE | Allergan, Inc. | 31bf1d6c-9719-4060-b6a3-409a2fe7b560 | 2026-09-15 | Warnings | FZ989GH94E |
| oxybutynin | OXYBUTYNIN | Redpharm Drug | 5b432aae-8a9d-8846-e063-6394a90a3b0d | 2026-09-12 | Warnings, Adverse reactions | ANDA202332 863636 L9F3D9RENQ |
| Leader Artificial Tears 15 mL | POLYVINYL ALCOHOL, POVIDONE | Cardinal Health | 8cccc589-3a8e-baad-e053-2a95a90ab8c7 | 2026-09-09 | Warnings | FZ989GH94E |
| FRESHKOTE PRESERVATIVE FREE LUBRICANT EYE DROPS | POVIDONE, POLYVINYL ALCOHOL SOLUTION | Harrow Eye, LLC | 049e9cc9-0663-53bc-e063-6294a90a2c4f | 2026-09-04 | Warnings | FZ989GH94E |
| Rohto Optic Glow | NAPHAZOLINE HYDROCHLORIDE, POVIDONE, PROPYLENE GLYCOL | The Mentholatum Company | df9c5f7c-96e6-4b2b-b8cb-21a6a3342dff | 2026-08-20 | Warnings | FZ989GH94E |
| Rohto All-In-One | HYPROMELLOSE, TETRAHYDROZOLINE HYDROCHLORIDE, ZINC SULFATE | The Mentholatum Company | 43e690e4-b381-46e3-838c-33aef5bdadde | 2026-08-20 | Warnings | 3NXW29V3WO |
| Rohto Preservative Free Dry Aid | POVIDONE, PROPYLENE GLYCOL | The Mentholatum Company | f4b1974c-2412-45f6-b79d-88b8a0bcb608 | 2026-08-18 | Warnings | FZ989GH94E |
| Rohto Dry-Aid | POVIDONE, PROPYLENE GLYCOL | The Mentholatum Company | 8ea5c6c9-48f4-406a-a2cb-9280c546d87d | 2026-08-18 | Warnings | FZ989GH94E |
| Leader Dry Eye Relief Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | CARDINAL HEALTH 110, LLC. DBA LEADER | 2ded4bda-b3c3-4521-8701-5c8446fd148b | 2026-08-17 | Warnings | 3NXW29V3WO |
| Caring Mill Lubricant Eye Drops | GLYCERIN, POVIDONE | FSA Store Inc | 2f735cdf-6530-1adf-e063-6394a90ab16a | 2026-08-16 | Warnings | FZ989GH94E |
| Dr. Shitong Photon Energy Eye Care Liquid | TETRAHYDROZOLINE HCL 0.05% HYPROMELLOSE 0.3% DR. SHITONG PHOTON ENERGY EYE CARE LIQUID | Wenzhou Yuyuan Pharmaceutical Co., Ltd. | 58ace434-55ef-17ef-e063-6294a90aa878 | 2026-08-10 | Warnings | 3NXW29V3WO |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | REMEDYREPACK INC. | 1a08a16a-f16d-4ef1-95bb-6943bcae0737 | 2026-07-28 | Warnings, Adverse reactions | L9F3D9RENQ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.